Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Post-Grafting Healthcare After Kidney Transplant

Post-Grafting Healthcare After Kidney Transplant

Thakur, Vivek

Paperback

Medical Reference

ISBN10: 6208472903
ISBN13: 9786208472900
Publisher: LAP Lambert Academic Publishing
Published: Aug 29 2025
Pages: 72
Weight: 0.24
Height: 0.17 Width: 6.00 Depth: 9.00
Language: English
POST-GRAFTING HEALTHCARE AFTER KIDNEY TRANSPLANT It is now well established that early kidney transplantation is associated with optimal outcomes in terms of patient and graft survival. In chronic kidney disease (CKD) - Stage V patients, kidney transplantation is considered as the treatment of choice because both survival and quality of life are often better than in people who are treated with dialysis. After kidney transplantation, patients receive a combination of immunosuppressive medications to prevent rejection of the transplanted kidney. Newer immunosuppressive drug regimens have resulted in improving the outcomes in kidney transplantation in the last two decades. These regimens usually contain a (CNI) calcineurin-inhibitor (tacrolimus or cyclosporine), steroids along with antiproliferative agent mycophenolate mofetil (MMF).The introduction of azathioprine as an effective oral immunosuppressant in the late 1950s resulted in achieving the first long-term survivors of transplants between genetically non-identical individuals (allografts). This drug acts by inhibiting purine synthesis.

Also from

Thakur, Vivek

View All

Also in

Medical Reference

View All